Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries.

The rapid assembly and in situ screening of focused combinatorial fragment libraries using CuAAC click chemistry is a highly robust and efficient strategy for establishing SAR and for discovering bioactive molecules. This review outlines the current status of this methodology in drug discovery application. The inherent limitations, challenges and prospects are critically discussed.

[1]  Hiroki Tsumoto,et al.  Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries. , 2012, Journal of medicinal chemistry.

[2]  M. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001 .

[3]  Valerie J Gillet,et al.  New directions in library design and analysis. , 2008, Current opinion in chemical biology.

[4]  Pengyu Yang,et al.  "Click" synthesis of small-molecule inhibitors targeting caspases. , 2008, Organic & biomolecular chemistry.

[5]  K. Kirshenbaum,et al.  Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2010, Chemical Society reviews.

[6]  Lorenz M Mayr,et al.  Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.

[7]  P. Zhan,et al.  Benzimidazole Heterocycle as a Privileged Scaffold in Antiviral Agents , 2012 .

[8]  K. Burgess,et al.  Peptidomimetics via copper-catalyzed azide-alkyne cycloadditions. , 2007, Chemical Society reviews.

[9]  Xiaojing Dong,et al.  Triazole-Linked Glycolipids Enhance the Susceptibility of MRSA to β-Lactam Antibiotics. , 2015, ACS medicinal chemistry letters.

[10]  G. Thoma,et al.  Selective inhibitors of the Janus kinase Jak3--Are they effective? , 2014, Bioorganic & medicinal chemistry letters.

[11]  V. Zoete,et al.  Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition. , 2012, Journal of medicinal chemistry.

[12]  Tatjana N. Parac-Vogt,et al.  Facile azide formation via diazotransfer reaction in a copper tube flow reactor , 2015 .

[13]  David S Goodsell,et al.  Rapid Diversity‐Oriented Synthesis in Microtiter Plates for In Situ Screening of HIV Protease Inhibitors , 2003, Chembiochem : a European journal of chemical biology.

[14]  C. Garbay,et al.  Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening. , 2009, Journal of combinatorial chemistry.

[15]  Peng Zhan,et al.  "Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets. , 2014, Molecular bioSystems.

[16]  L. Jones,et al.  Click chemistry patents and their impact on drug discovery and chemical biology. , 2015, Pharmaceutical patent analyst.

[17]  K. Shirahige,et al.  Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8‐Selective Inhibitors , 2014, ChemMedChem.

[18]  R. Berg,et al.  Advancements in the mechanistic understanding of the copper-catalyzed azide–alkyne cycloaddition , 2013, Beilstein journal of organic chemistry.

[19]  Eelco Ruijter,et al.  Multicomponent reaction design in the quest for molecular complexity and diversity. , 2011, Angewandte Chemie.

[20]  S. Yao,et al.  In situ "click" assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups. , 2008, Organic letters.

[21]  Xiao‐Peng He,et al.  CuAAC Click Chemistry Accelerates the Discovery of Novel Chemical Scaffolds as Promising Protein Tyrosine Phosphatases Inhibitors , 2012, Current medicinal chemistry.

[22]  Dariusz Matosiuk,et al.  Click chemistry for drug development and diverse chemical-biology applications. , 2013, Chemical reviews.

[23]  Karunakaran A Kalesh,et al.  High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry. , 2009, Organic letters.

[24]  V. Pore,et al.  Click chemistry: 1,2,3-triazoles as pharmacophores. , 2011, Chemistry, an Asian journal.

[25]  Chi‐Huey Wong,et al.  A Potent and Highly Selective Inhibitor of Human α-1,3-Fucosyltransferase via Click Chemistry , 2003 .

[26]  Chi‐Huey Wong,et al.  A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors. , 2002, Chemistry & biology.

[27]  H. Kolb,et al.  The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.

[28]  S. Laufer,et al.  Solution-phase parallel synthesis of ruxolitinib-derived Janus kinase inhibitors via copper-catalyzed azide-alkyne cycloaddition. , 2015, ACS combinatorial science.

[29]  Chi‐Huey Wong,et al.  Microtiter plate based chemistry and in situ screening: a useful approach for rapid inhibitor discovery. , 2006, Organic & biomolecular chemistry.

[30]  W. Ye,et al.  The application of click chemistry in the synthesis of agents with anticancer activity , 2015, Drug design, development and therapy.

[31]  Heejun Kim,et al.  Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces. , 2014, Journal of the American Chemical Society.

[32]  Younan Xia,et al.  Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry. , 2014, Angewandte Chemie.

[33]  Giuseppe Bifulco,et al.  A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry. , 2010, Journal of medicinal chemistry.

[34]  Xin Qiao,et al.  Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents. , 2012, Journal of medicinal chemistry.

[35]  William L Jorgensen,et al.  Efficient drug lead discovery and optimization. , 2009, Accounts of chemical research.

[36]  Karunakaran A Kalesh,et al.  Rapid synthesis of Abelson tyrosine kinase inhibitors using click chemistry. , 2009, Organic & biomolecular chemistry.

[37]  Peng Zhan,et al.  "Old friends in new guise": exploiting privileged structures for scaffold re-evolution/refining. , 2014, Combinatorial chemistry & high throughput screening.

[38]  P. Bonneau,et al.  Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases. , 2009, Bioorganic & medicinal chemistry letters.

[39]  Morten Meldal,et al.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.

[40]  Peng Zhan,et al.  Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities. , 2013, Current pharmaceutical design.

[41]  Peng Zhan,et al.  Multivalent agents: a novel concept and preliminary practice in Anti-HIV drug discovery. , 2013, Current medicinal chemistry.

[42]  Zeng Li,et al.  [Application of efficient synthetic techniques in drug research]. , 2013, Yao xue xue bao = Acta pharmaceutica Sinica.

[43]  A. Burke,et al.  New click-chemistry methods for 1,2,3-triazoles synthesis: recent advances and applications , 2015 .

[44]  Takashi Okamoto,et al.  Identification of Highly Selective and Potent Histone Deacetylase 3 Inhibitors Using Click Chemistry-Based Combinatorial Fragment Assembly , 2013, PloS one.

[45]  A. Mai,et al.  Sirtuin modulators: an updated patent review (2012 – 2014) , 2015, Expert opinion on therapeutic patents.

[46]  R. Chan,et al.  Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). , 2010, Journal of medicinal chemistry.

[47]  Michael D. Womble,et al.  Halide inhibition of the copper-catalysed azide-alkyne cycloaddition. , 2015, Organic & biomolecular chemistry.

[48]  Chi‐Huey Wong,et al.  Epoxide opening in water and screening in situ for rapid discovery of enzyme inhibitors in microtiter plates. , 2006, Bioorganic & medicinal chemistry.

[49]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[50]  P. Zhan,et al.  8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential , 2015 .

[51]  D. Fabbro,et al.  Advances in kinase targeting: current clinical use and clinical trials. , 2014, Trends in pharmacological sciences.

[52]  Christopher N Bowman,et al.  Thiol-ene click chemistry. , 2010, Angewandte Chemie.

[53]  M. Ghadiri,et al.  Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. , 2009, Journal of medicinal chemistry.

[54]  M. Uttamchandani,et al.  Rapid assembly of matrix metalloprotease inhibitors using click chemistry. , 2006, Organic letters.

[55]  Karunakaran A Kalesh,et al.  High-throughput synthesis of azide libraries suitable for direct "click" chemistry and in situ screening. , 2009, Organic & biomolecular chemistry.

[56]  Peng Zhan,et al.  Identification of novel SIRT2-selective inhibitors using a click chemistry approach. , 2014, Bioorganic & medicinal chemistry letters.

[57]  Mahesh Uttamchandani,et al.  Rapid assembly and in situ screening of bidentate inhibitors of protein tyrosine phosphatases. , 2006, Organic letters.

[58]  S. Grant,et al.  Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights. , 2014, Pharmacology & therapeutics.

[59]  David S Goodsell,et al.  1,2,3‐Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV‐1 Protease Inhibitors , 2005, Chembiochem : a European journal of chemical biology.

[60]  Morten Meldal,et al.  Cu-catalyzed azide-alkyne cycloaddition. , 2008, Chemical reviews.

[61]  Kristian Helin,et al.  Chromatin proteins and modifications as drug targets , 2013, Nature.

[62]  J. Paulson,et al.  On-chip synthesis and screening of a sialoside library yields a high affinity ligand for Siglec-7. , 2013, ACS chemical biology.

[63]  S. Schreiber,et al.  Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[64]  A. Massarotti,et al.  Are 1,4‐ and 1,5‐Disubstituted 1,2,3‐Triazoles Good Pharmacophoric Groups? , 2014, ChemMedChem.

[65]  A. Olson,et al.  Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization. , 2006, Journal of medicinal chemistry.

[66]  Giovanni Sorba,et al.  Click chemistry reactions in medicinal chemistry: Applications of the 1,3‐dipolar cycloaddition between azides and alkynes , 2008, Medicinal research reviews.

[67]  D. Scott,et al.  Fragment-based approaches in drug discovery and chemical biology. , 2012, Biochemistry.

[68]  J. Ryu,et al.  A rapid synthesis of lavendustin-mimetic small molecules by click fragment assembly. , 2010, Bioorganic & medicinal chemistry letters.

[69]  Karunakaran A Kalesh,et al.  Methods of using click chemistry in the discovery of enzyme inhibitors , 2007, Nature Protocols.

[70]  Karunakaran A Kalesh,et al.  The use of click chemistry in the emerging field of catalomics. , 2010, Organic & biomolecular chemistry.

[71]  Peng Zhan,et al.  Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators. , 2015, Journal of medicinal chemistry.

[72]  Pilar Elías-Rodríguez,et al.  Rapid discovery of potent α-fucosidase inhibitors by in situ screening of a library of (pyrrolidin-2-yl)triazoles. , 2014, Organic & biomolecular chemistry.

[73]  P. Zhan,et al.  Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry. , 2013, Current pharmaceutical design.

[74]  Yechun Xu,et al.  Discovery of pyrazole as C-terminus of selective BACE1 inhibitors. , 2013, European journal of medicinal chemistry.

[75]  K. Karlin,et al.  A bis-acetonitrile two-coordinate copper(I) complex: synthesis and characterization of highly soluble B(C(6)F(5))(4)(-) salts of [Cu(MeCN)(2)](+) and [Cu(MeCN)(4)](+). , 2002, Inorganic chemistry.

[76]  Judith M. LaLonde,et al.  Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. , 2008, Journal of medicinal chemistry.

[77]  E. Hennessy,et al.  Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screening. , 2014, Journal of medicinal chemistry.

[78]  M. Totrov,et al.  Triazole-linked reduced amide isosteres: an approach for the fragment-based drug discovery of anti-Alzheimer's BACE1 inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[79]  Shaibal Banerjee,et al.  Pd-catalyzed regioselective arylation on the C-5 position of N-aryl 1,2,3-triazoles. , 2015, The Journal of organic chemistry.

[80]  Andrew J. P. White,et al.  Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. , 2012, Journal of medicinal chemistry.

[81]  C. Porco,et al.  Direct Evidence of a Dinuclear Copper Intermediate in Cu(I)-Catalyzed Azide-Alkyne Cycloadditions , 2013, Science.

[82]  C. Slugovc,et al.  Kinetic studies of inverse electron demand Diels–Alder reactions (iEDDA) of norbornenes and 3,6-dipyridin-2-yl-1,2,4,5-tetrazine , 2014, Tetrahedron letters.

[83]  E. De Clercq,et al.  Functional roles of azoles motif in anti-HIV agents. , 2011, Current medicinal chemistry.

[84]  A. Llebaria,et al.  New glucocerebrosidase inhibitors by exploration of chemical diversity of N-substituted aminocyclitols using click chemistry and in situ screening. , 2011, Journal of medicinal chemistry.

[85]  R. Lamb,et al.  Flipping in the Pore: Discovery of Dual Inhibitors That Bind in Different Orientations to the Wild-Type versus the Amantadine-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel , 2014, Journal of the American Chemical Society.

[86]  J. Hah,et al.  Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors. , 2014, Bioorganic & medicinal chemistry.

[87]  Peng Zhan,et al.  Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs. , 2009, Mini reviews in medicinal chemistry.

[88]  M. Sawa,et al.  Design and combinatorial synthesis of a novel kinase-focused library using click chemistry-based fragment assembly. , 2012, Bioorganic & medicinal chemistry letters.

[89]  Peng Zhan,et al.  Design strategies of novel NNRTIs to overcome drug resistance. , 2009, Current medicinal chemistry.